The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinoma.
about
Long noncoding RNAs in hepatocellular carcinoma: Novel insights into their mechanismGenetic and epigenetic aspects of initiation and progression of hepatocellular carcinomaDownregulation of UHRF1 increases tumor malignancy by activating the CXCR4/AKT-JNK/IL-6/Snail signaling axis in hepatocellular carcinoma cells.Long non-coding RNA Loc554202 induces apoptosis in colorectal cancer cells via the caspase cleavage cascadesElevated expression of UHRF1 predicts unfavorable prognosis for patients with hepatocellular carcinoma.Linc00152 promotes proliferation in gastric cancer through the EGFR-dependent pathwayLinc-POU3F3 promotes cell proliferation in gastric cancer via increasing T-reg distribution.Associations between polymorphisms of long non-coding RNA MEG3 and risk of colorectal cancer in ChineseArmored long non-coding RNA MEG3 targeting EGFR based on recombinant MS2 bacteriophage virus-like particles against hepatocellular carcinoma.Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2, LSD1 in colorectal cancer.Functional Roles and Therapeutic Applications of Exosomes in Hepatocellular Carcinoma.Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer.Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma.Bidirectional transcription of Linc00441 and RB1 via H3K27 modification-dependent way promotes hepatocellular carcinoma.Long noncoding RNA MEG3, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysis.Non-Coding RNAs in Primary Liver Cancer.The role of lncRNAs in hepatocellular carcinoma: opportunities as novel targets for pharmacological intervention.The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer.Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs.UHRF1 promotes breast cancer progression by suppressing KLF17 expression by hypermethylating its promoterLong Noncoding RNAs Act as Novel Biomarkers for Hepatocellular Carcinoma: Progress and Prospects.Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implicationslncRNAs as prognostic molecular biomarkers in hepatocellular carcinoma: a systematic review and meta-analysis.New Insights into the Epigenetics of Hepatocellular Carcinoma.LncRNA EWSAT1 promotes ovarian cancer progression through targeting miR-330-5p expressionPotential applications of MEG3 in cancer diagnosis and prognosis.Defining baseline epigenetic landscapes in the rat liver.Long non-coding RNA SNHG15 inhibits P15 and KLF2 expression to promote pancreatic cancer proliferation through EZH2-mediated H3K27me3.Downregulation of the Long Non-Coding RNA Meg3 Promotes Angiogenesis After Ischemic Brain Injury by Activating Notch Signaling.Long Noncoding RNAs as a Key Player in Hepatocellular Carcinoma.The mechanism of long non-coding RNA MEG3 for hepatic ischemia-reperfusion: Mediated by miR-34a/Nrf2 signaling pathway.Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis.The Role of Long Non-Coding RNAs in Hepatocarcinogenesis.Overexpression of UHRF1 promotes silencing of tumor suppressor genes and predicts outcome in hepatoblastoma.Hepatitis C virus core impacts expression of miR122 and miR204 involved in carcinogenic progression via regulation of TGFBRAP1 and HOTTIP expression.Long non-coding RNAs: crucial regulators of gastrointestinal cancer cell proliferation.Long non-coding RNA MEG3 suppresses survival, migration, and invasion of cervical cancer
P2860
Q26775818-EF2F6A3E-2710-4DC3-B889-2E97E2BEA577Q26784412-D373EE8F-4545-4EAF-A671-53D2666FB7E4Q33765984-89BC62EB-52A0-42B1-AEA9-5C993E9881F8Q36053900-B78F3BFC-DA6C-4147-BED1-2B3E2D9220E6Q36095316-F154E549-DF86-4549-A3ED-69B83919C663Q36246352-920CD8D6-D51D-4488-852F-947EDE0F14F6Q36420239-F820F8D5-5395-443A-AE8F-E98D251059C9Q37109931-A65EF8E3-2DA0-40F0-A216-59B2EA807796Q37269190-5156D23B-A482-472A-B786-BD101643DF46Q37627435-F97A891C-3576-4E0B-9AE4-B88A6C38C408Q37654423-A5F7E12C-E0B0-40E6-9841-056EB0202174Q37694715-D97B1219-CADF-4866-B789-350C0F664B30Q37705867-DE3F050C-3280-46E2-9565-BC05C9574D50Q37745567-0249AF63-E97E-4AB8-B054-A9CBF6A430A8Q37745920-3AF7ABFA-C443-4867-AD93-9857B014FE60Q38541359-B15452A9-EA50-4E9A-8BCA-2F317658F232Q38630563-0A6A8313-46B7-4E5F-BF13-1B56FDBCF396Q39304639-24936523-92B4-4FE3-9C97-970E72067591Q39370677-6C4614E5-541E-44D1-BB8B-B049F0565CC3Q41098287-B1009F00-C78E-4775-A368-8F0603693413Q41408442-504C1AD0-AE12-4307-BCE6-301F17B68E28Q41608473-339D954C-388F-4DB2-BA42-C1A8E88DC03FQ41708847-F33E831C-9572-407D-A0F0-5CA91790E77BQ41990459-ECB90CC9-16D6-41DE-B9C9-6B5D1953CBE1Q42068041-CE78F9A2-982F-4FB5-85B3-8BEF818B9C34Q42700665-48E00F23-9D03-428B-BA3F-E75D04F80B5DQ46262957-CC71C9DF-2C03-477D-AE92-084558C36B58Q47135296-4D5671FA-9D3A-4376-B433-DED17360AD0DQ47156458-1CE732A5-0F63-4E6D-B968-7003205C39B2Q47393672-3FB58CDE-3389-4FDB-BD95-F88BAD547960Q48124558-47BB1217-276C-400B-9F60-201EAC8EA8EAQ49497915-EF9548C3-E2B0-4B7A-BE70-95C0A733D4E5Q52370690-2C6B6A73-414D-4042-AB71-FAFCEA3DEEA4Q52672988-044070CC-A625-4512-B929-6B30A866DFC1Q53177200-64F4FAD3-DB26-4575-8EFF-E4C588F38C11Q55340761-941F32D9-5270-42F6-B9C7-9C641671C297Q58735655-B4055DC2-FD08-47F7-AB41-972D1FCBCD32
P2860
The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
The aberrant expression of MEG ...... s of hepatocellular carcinoma.
@en
type
label
The aberrant expression of MEG ...... s of hepatocellular carcinoma.
@en
prefLabel
The aberrant expression of MEG ...... s of hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
The aberrant expression of MEG ...... s of hepatocellular carcinoma.
@en
P2093
Beicheng Sun
Junwei Tang
Xudong Zhang
P2860
P304
P356
10.1002/MC.22270
P50
P577
2015-01-16T00:00:00Z